0001829126-21-006116.txt : 20210707
0001829126-21-006116.hdr.sgml : 20210707
20210707165538
ACCESSION NUMBER: 0001829126-21-006116
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210707
DATE AS OF CHANGE: 20210707
EFFECTIVENESS DATE: 20210707
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inspyr Therapeutics, Inc.
CENTRAL INDEX KEY: 0001421204
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-405491
FILM NUMBER: 211077978
BUSINESS ADDRESS:
STREET 1: 2629 TOWNSGATE RD, SUITE 215
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
BUSINESS PHONE: (210) 479-8112
MAIL ADDRESS:
STREET 1: 2629 TOWNSGATE RD, SUITE 215
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
FORMER COMPANY:
FORMER CONFORMED NAME: GENSPERA INC
DATE OF NAME CHANGE: 20071213
D
1
primary_doc.xml
X0708
D
LIVE
0001421204
Inspyr Therapeutics, Inc.
2629 TOWNSGATE RD
SUITE 215
WESTLAKE VILLAGE
CA
CALIFORNIA
91361
(818) 597-7552
DELAWARE
GenSpera, Inc.
GENSPERA INC
Corporation
true
Scott
Ogilvie
2629 Townsgate Road
Suite 215
Westlake Village
CA
CALIFORNIA
91361
Director
Claire
Thom
2629 Townsgate Road
Suite 215
Westlake Village
CA
CALIFORNIA
91361
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-06-18
false
true
true
true
false
100000
600000
600000
0
Includes (i) $500,000 in cash and (ii) $100,000 in cancellation of debt
false
2
0
0
0
false
Inspyr Therapeutics, Inc.
/s/ Scott Ogilvie
Scott Ogilvie
Director
2021-07-07